Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.

Identifieur interne : 003903 ( Main/Exploration ); précédent : 003902; suivant : 003904

Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.

Auteurs : Valery L. Feigin [Nouvelle-Zélande] ; Priya G. Parmar ; Suzanne Barker-Collo ; Derrick A. Bennett ; Craig S. Anderson ; Amanda G. Thrift ; Birgitta Stegmayr ; Peter M. Rothwell ; Maurice Giroud ; Yannick Bejot ; Phillip Carvil ; Rita Krishnamurthi ; Nikola Kasabov

Source :

RBID : pubmed:24757102

Descripteurs français

English descriptors

Abstract

Although the research linking cardiovascular disorders to geomagnetic activity is accumulating, robust evidence for the impact of geomagnetic activity on stroke occurrence is limited and controversial.

DOI: 10.1161/STROKEAHA.113.004577
PubMed: 24757102


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.</title>
<author>
<name sortKey="Feigin, Valery L" sort="Feigin, Valery L" uniqKey="Feigin V" first="Valery L" last="Feigin">Valery L. Feigin</name>
<affiliation wicri:level="1">
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.). valery.feigin@aut.ac.nz.</nlm:affiliation>
<country wicri:rule="url">Nouvelle-Zélande</country>
</affiliation>
</author>
<author>
<name sortKey="Parmar, Priya G" sort="Parmar, Priya G" uniqKey="Parmar P" first="Priya G" last="Parmar">Priya G. Parmar</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Barker Collo, Suzanne" sort="Barker Collo, Suzanne" uniqKey="Barker Collo S" first="Suzanne" last="Barker-Collo">Suzanne Barker-Collo</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bennett, Derrick A" sort="Bennett, Derrick A" uniqKey="Bennett D" first="Derrick A" last="Bennett">Derrick A. Bennett</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Craig S" sort="Anderson, Craig S" uniqKey="Anderson C" first="Craig S" last="Anderson">Craig S. Anderson</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Thrift, Amanda G" sort="Thrift, Amanda G" uniqKey="Thrift A" first="Amanda G" last="Thrift">Amanda G. Thrift</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Stegmayr, Birgitta" sort="Stegmayr, Birgitta" uniqKey="Stegmayr B" first="Birgitta" last="Stegmayr">Birgitta Stegmayr</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Giroud, Maurice" sort="Giroud, Maurice" uniqKey="Giroud M" first="Maurice" last="Giroud">Maurice Giroud</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bejot, Yannick" sort="Bejot, Yannick" uniqKey="Bejot Y" first="Yannick" last="Bejot">Yannick Bejot</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Carvil, Phillip" sort="Carvil, Phillip" uniqKey="Carvil P" first="Phillip" last="Carvil">Phillip Carvil</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Krishnamurthi, Rita" sort="Krishnamurthi, Rita" uniqKey="Krishnamurthi R" first="Rita" last="Krishnamurthi">Rita Krishnamurthi</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kasabov, Nikola" sort="Kasabov, Nikola" uniqKey="Kasabov N" first="Nikola" last="Kasabov">Nikola Kasabov</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24757102</idno>
<idno type="pmid">24757102</idno>
<idno type="doi">10.1161/STROKEAHA.113.004577</idno>
<idno type="wicri:Area/PubMed/Corpus">003706</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003706</idno>
<idno type="wicri:Area/PubMed/Curation">003592</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003592</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003592</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003592</idno>
<idno type="wicri:Area/Ncbi/Merge">001983</idno>
<idno type="wicri:Area/Ncbi/Curation">001983</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001983</idno>
<idno type="wicri:Area/Main/Merge">003939</idno>
<idno type="wicri:Area/Main/Curation">003903</idno>
<idno type="wicri:Area/Main/Exploration">003903</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.</title>
<author>
<name sortKey="Feigin, Valery L" sort="Feigin, Valery L" uniqKey="Feigin V" first="Valery L" last="Feigin">Valery L. Feigin</name>
<affiliation wicri:level="1">
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.). valery.feigin@aut.ac.nz.</nlm:affiliation>
<country wicri:rule="url">Nouvelle-Zélande</country>
</affiliation>
</author>
<author>
<name sortKey="Parmar, Priya G" sort="Parmar, Priya G" uniqKey="Parmar P" first="Priya G" last="Parmar">Priya G. Parmar</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Barker Collo, Suzanne" sort="Barker Collo, Suzanne" uniqKey="Barker Collo S" first="Suzanne" last="Barker-Collo">Suzanne Barker-Collo</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bennett, Derrick A" sort="Bennett, Derrick A" uniqKey="Bennett D" first="Derrick A" last="Bennett">Derrick A. Bennett</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Anderson, Craig S" sort="Anderson, Craig S" uniqKey="Anderson C" first="Craig S" last="Anderson">Craig S. Anderson</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Thrift, Amanda G" sort="Thrift, Amanda G" uniqKey="Thrift A" first="Amanda G" last="Thrift">Amanda G. Thrift</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Stegmayr, Birgitta" sort="Stegmayr, Birgitta" uniqKey="Stegmayr B" first="Birgitta" last="Stegmayr">Birgitta Stegmayr</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Giroud, Maurice" sort="Giroud, Maurice" uniqKey="Giroud M" first="Maurice" last="Giroud">Maurice Giroud</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Bejot, Yannick" sort="Bejot, Yannick" uniqKey="Bejot Y" first="Yannick" last="Bejot">Yannick Bejot</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Carvil, Phillip" sort="Carvil, Phillip" uniqKey="Carvil P" first="Phillip" last="Carvil">Phillip Carvil</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Krishnamurthi, Rita" sort="Krishnamurthi, Rita" uniqKey="Krishnamurthi R" first="Rita" last="Krishnamurthi">Rita Krishnamurthi</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kasabov, Nikola" sort="Kasabov, Nikola" uniqKey="Kasabov N" first="Nikola" last="Kasabov">Nikola Kasabov</name>
<affiliation>
<nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Stroke</title>
<idno type="eISSN">1524-4628</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Australia (epidemiology)</term>
<term>Europe (epidemiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Phenomena</term>
<term>Male</term>
<term>Middle Aged</term>
<term>New Zealand (epidemiology)</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Stroke (epidemiology)</term>
<term>Stroke (etiology)</term>
<term>Stroke (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Accident vasculaire cérébral ()</term>
<term>Accident vasculaire cérébral (épidémiologie)</term>
<term>Accident vasculaire cérébral (étiologie)</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Australie (épidémiologie)</term>
<term>Europe (épidémiologie)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nouvelle-Zélande (épidémiologie)</term>
<term>Phénomènes magnétiques</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Australia</term>
<term>Europe</term>
<term>New Zealand</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Accident vasculaire cérébral</term>
<term>Australie</term>
<term>Europe</term>
<term>Nouvelle-Zélande</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Accident vasculaire cérébral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Phenomena</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Accident vasculaire cérébral</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Phénomènes magnétiques</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Australie</term>
<term>Nouvelle-Zélande</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Although the research linking cardiovascular disorders to geomagnetic activity is accumulating, robust evidence for the impact of geomagnetic activity on stroke occurrence is limited and controversial.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Nouvelle-Zélande</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Anderson, Craig S" sort="Anderson, Craig S" uniqKey="Anderson C" first="Craig S" last="Anderson">Craig S. Anderson</name>
<name sortKey="Barker Collo, Suzanne" sort="Barker Collo, Suzanne" uniqKey="Barker Collo S" first="Suzanne" last="Barker-Collo">Suzanne Barker-Collo</name>
<name sortKey="Bejot, Yannick" sort="Bejot, Yannick" uniqKey="Bejot Y" first="Yannick" last="Bejot">Yannick Bejot</name>
<name sortKey="Bennett, Derrick A" sort="Bennett, Derrick A" uniqKey="Bennett D" first="Derrick A" last="Bennett">Derrick A. Bennett</name>
<name sortKey="Carvil, Phillip" sort="Carvil, Phillip" uniqKey="Carvil P" first="Phillip" last="Carvil">Phillip Carvil</name>
<name sortKey="Giroud, Maurice" sort="Giroud, Maurice" uniqKey="Giroud M" first="Maurice" last="Giroud">Maurice Giroud</name>
<name sortKey="Kasabov, Nikola" sort="Kasabov, Nikola" uniqKey="Kasabov N" first="Nikola" last="Kasabov">Nikola Kasabov</name>
<name sortKey="Krishnamurthi, Rita" sort="Krishnamurthi, Rita" uniqKey="Krishnamurthi R" first="Rita" last="Krishnamurthi">Rita Krishnamurthi</name>
<name sortKey="Parmar, Priya G" sort="Parmar, Priya G" uniqKey="Parmar P" first="Priya G" last="Parmar">Priya G. Parmar</name>
<name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<name sortKey="Stegmayr, Birgitta" sort="Stegmayr, Birgitta" uniqKey="Stegmayr B" first="Birgitta" last="Stegmayr">Birgitta Stegmayr</name>
<name sortKey="Thrift, Amanda G" sort="Thrift, Amanda G" uniqKey="Thrift A" first="Amanda G" last="Thrift">Amanda G. Thrift</name>
</noCountry>
<country name="Nouvelle-Zélande">
<noRegion>
<name sortKey="Feigin, Valery L" sort="Feigin, Valery L" uniqKey="Feigin V" first="Valery L" last="Feigin">Valery L. Feigin</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003903 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003903 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24757102
   |texte=   Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24757102" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024